Allegiant Private Advisors’s Medtronic MDT Stock Holding History

Allegiant Private Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$211K	Hold	1,702	–	–	0.03%	161
2021 Q1	$201K	Sell	1,702 -130	-7%	-$15.2K	0.04%	150
2020 Q4	$215K	Buy	+1,832	New	+$202K	0.04%	134

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allegiant Private Advisors's MDT Position: Q2 2021 in Review

Allegiant Private Advisors held its Medtronic (MDT) position steady in Q2 2021 at 1,702 shares worth $211K. The position accounts for 0.03% of the portfolio, ranked #161.

Allegiant Private Advisors first reported a position in MDT in Q4 2020 and has held it in 3 quarters since. The position peaked at $215K in Q4 2020. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

Allegiant Private Advisors held 1,702 shares of Medtronic worth $211K as of Q2 2021.
Allegiant Private Advisors left its Medtronic share count unchanged in Q2 2021.
Medtronic made up 0.03% of Allegiant Private Advisors's portfolio in Q2 2021, its #161 holding.
Allegiant Private Advisors first reported a position in Medtronic in Q4 2020 and has held it in 3 quarters since.
Allegiant Private Advisors's Medtronic position peaked at $215K in Q4 2020.
2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.